• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从糖尿病视网膜病变病程中诊断出的慢性髓性白血病。

Chronic myeloid leukemia diagnosed from the course of diabetic retinopathy.

作者信息

Bhattacharjee Raghudev, Mishra Avinash, Mishra Chitaranjan, Bhawsinka Yoshita

机构信息

Ophthalmologist, VR Specialist, Trilochan Netralaya, Sambal Pur, Odisha, India.

Professor & Head (Ophthalmology), Military Hospital Jalandhar, India.

出版信息

Med J Armed Forces India. 2024 Sep-Oct;80(5):599-603. doi: 10.1016/j.mjafi.2022.12.009. Epub 2023 Jan 30.

DOI:10.1016/j.mjafi.2022.12.009
PMID:39309576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411308/
Abstract

We report a case of chronic myeloid leukemia (CML), which was diagnosed during the management of proliferative retinopathy (PR) in a patient with type I diabetes mellitus due to the fulminant nature of the PR. This case highlights the importance of vigilance on the part of the ophthalmologist in the diagnosis of co-existing systemic disorders, notably hematological malignancy, which aggravates the posterior segment vasculopathy of the eye and the management of which is crucial for the patient. We also describe a short literature review on the clinical features, mechanism of the posterior segment vasculopathy of the eye, and management of PR co-existing in a patient with CML.

摘要

我们报告了一例慢性髓性白血病(CML)病例,该病例是在一名I型糖尿病患者增殖性视网膜病变(PR)的治疗过程中因PR的暴发性而被诊断出来的。该病例强调了眼科医生在诊断并存的全身性疾病(尤其是血液系统恶性肿瘤)方面保持警惕的重要性,这种疾病会加重眼部后段血管病变,而其治疗对患者至关重要。我们还对CML患者并存的PR的临床特征、眼部后段血管病变机制及治疗进行了简短的文献综述。

相似文献

1
Chronic myeloid leukemia diagnosed from the course of diabetic retinopathy.从糖尿病视网膜病变病程中诊断出的慢性髓性白血病。
Med J Armed Forces India. 2024 Sep-Oct;80(5):599-603. doi: 10.1016/j.mjafi.2022.12.009. Epub 2023 Jan 30.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
3
Laser photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的激光光凝治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
5
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
6
Laser therapy for retinopathy in sickle cell disease.镰状细胞病视网膜病变的激光治疗
Cochrane Database Syst Rev. 2015 Oct 9;2015(10):CD010790. doi: 10.1002/14651858.CD010790.pub2.
7
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制
Cochrane Database Syst Rev. 2015 Jan 31;1:CD006127. doi: 10.1002/14651858.CD006127.pub2.
8
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
9
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
10
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.

本文引用的文献

1
Authors' response: Proliferative retinopathy in chronic myeloid leukemia and diabetes: A "double whammy".
Surv Ophthalmol. 2022 Nov-Dec;67(6):1731-1732. doi: 10.1016/j.survophthal.2022.07.004. Epub 2022 Jul 21.
2
Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation.与全视网膜光凝治疗后糖尿病性视网膜病变进展相关的危险因素。
Sci Rep. 2021 Jul 5;11(1):13850. doi: 10.1038/s41598-021-93384-5.
3
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future.慢性髓性白血病:过去、现在和未来的典范疾病。
Cells. 2021 Jan 10;10(1):117. doi: 10.3390/cells10010117.
4
ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUS.糖尿病患者以非典型增生性视网膜病变为首发表现的慢性髓系白血病。
Retin Cases Brief Rep. 2023 Jan 1;17(1):61-64. doi: 10.1097/ICB.0000000000001100.
5
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML.白血病干细胞:CML 和 AML 中的相似性、差异性和临床前景。
Nat Rev Cancer. 2020 Mar;20(3):158-173. doi: 10.1038/s41568-019-0230-9. Epub 2020 Jan 6.
6
Chronic myeloid leukaemia accelerates proliferative retinopathy in patients with co-existent diabetes: A risk factor not to be ignored.慢性髓性白血病加速并存糖尿病患者的增殖性视网膜病变:一个不容忽视的危险因素。
Eur J Ophthalmol. 2021 Jan;31(1):226-233. doi: 10.1177/1120672119875341. Epub 2019 Sep 12.
7
Bilateral proliferative retinopathy in B-cell acute lymphoblastic leukemia.B 细胞急性淋巴细胞白血病中的双侧增殖性视网膜病变。
Indian J Ophthalmol. 2018 Jan;66(1):148-151. doi: 10.4103/ijo.IJO_608_17.
8
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.单细胞转录组学揭示慢性髓性白血病干细胞的独特分子特征。
Nat Med. 2017 Jun;23(6):692-702. doi: 10.1038/nm.4336. Epub 2017 May 15.
9
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
10
Chronic myeloid leukemia diagnosed in a patient with uncontrolled proliferative diabetic retinopathy.
Retin Cases Brief Rep. 2015 Summer;9(3):210-3. doi: 10.1097/ICB.0000000000000140.